首页 > 最新文献

Acta virologica最新文献

英文 中文
Molecular characterization of multiple putative novel hepatitis B virus spliced DNA from a chronic hepatitis B patient 慢性乙型肝炎患者多种推测的新型乙型肝炎病毒剪接DNA的分子特征
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-07-04 DOI: 10.3389/av.2023.11663
Yihan Xiao, Zhigang Cui, Xiaojun Zhou, Zong-Hua Li, Lihua Li, Lixian Wu, Long Sun, Xiuji Cui
Spliced hepatitis B virus (HBV) RNA has been reported to affect the viral life cycle and progression of liver disease. As much as 30% of HBV RNA are spliced in infected cells, and some can be reverse transcribed to spliced DNA. To date, only a small number of spliced DNA have been identified and the majority require further investigation. This study aimed to identify the types of spliced DNA from the sera of a chronic hepatitis B patient. HBV DNA was isolated from the serum, and both full-length and spliced DNA were amplified by PCR. The amplified PCR products were then subcloned and sequenced using a Sanger sequence analysis. As a result, 19 types of spliced DNA were identified, 11 of which were assumed to be putative novel spliced DNA. These spliced DNA were doubly spliced with varied splice donor sites and splice acceptor sites. In addition to the frequently detected HBV SP1, SP2, and SP4, we also identified 11 putative novel spliced DNA in the serum. These findings indicate the complexity of HBV RNA splicing during viral life cycle.
剪接乙型肝炎病毒(HBV) RNA已被报道影响病毒生命周期和肝脏疾病的进展。多达30%的HBV RNA在感染细胞中被剪接,其中一些可以逆转录为剪接的DNA。到目前为止,只有一小部分剪接DNA被确定,大多数需要进一步研究。本研究旨在从慢性乙型肝炎患者的血清中鉴定剪接DNA的类型。从血清中分离HBV DNA,用PCR扩增全长DNA和剪接DNA。扩增的PCR产物随后进行亚克隆,并使用桑格序列分析进行测序。结果,鉴定出19种剪接DNA,其中11种被认为是假定的新剪接DNA。这些剪接的DNA通过不同的剪接供体位点和剪接受体位点进行双剪接。除了经常检测到的HBV SP1、SP2和SP4外,我们还在血清中发现了11种推测的新型剪接DNA。这些发现表明HBV RNA剪接在病毒生命周期中的复杂性。
{"title":"Molecular characterization of multiple putative novel hepatitis B virus spliced DNA from a chronic hepatitis B patient","authors":"Yihan Xiao, Zhigang Cui, Xiaojun Zhou, Zong-Hua Li, Lihua Li, Lixian Wu, Long Sun, Xiuji Cui","doi":"10.3389/av.2023.11663","DOIUrl":"https://doi.org/10.3389/av.2023.11663","url":null,"abstract":"Spliced hepatitis B virus (HBV) RNA has been reported to affect the viral life cycle and progression of liver disease. As much as 30% of HBV RNA are spliced in infected cells, and some can be reverse transcribed to spliced DNA. To date, only a small number of spliced DNA have been identified and the majority require further investigation. This study aimed to identify the types of spliced DNA from the sera of a chronic hepatitis B patient. HBV DNA was isolated from the serum, and both full-length and spliced DNA were amplified by PCR. The amplified PCR products were then subcloned and sequenced using a Sanger sequence analysis. As a result, 19 types of spliced DNA were identified, 11 of which were assumed to be putative novel spliced DNA. These spliced DNA were doubly spliced with varied splice donor sites and splice acceptor sites. In addition to the frequently detected HBV SP1, SP2, and SP4, we also identified 11 putative novel spliced DNA in the serum. These findings indicate the complexity of HBV RNA splicing during viral life cycle.","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47542519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of the SARS-CoV-2 Omicron (B.1.1.529) variant and booster vaccine doses on the seroprevalence of specific IgG antibodies in the staff of the Slovak Academy of Sciences SARS-CoV-2 Omicron (B.1.1.529)变体和加强疫苗剂量对斯洛伐克科学院工作人员特异性IgG抗体血清阳性率的影响
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-06-28 DOI: 10.3389/av.2023.11637
I. Kajanová, L. Jelenska, Ľ. Lukáčiková, Katarina Grossmannova, Martina Belisova, Nikola Istvanova, Natalia Gasparovicová, V. Zelník, S. Pastoreková, Z. Radiková, J. Kopáček
The presented seroprevalence study focused on specific antibodies to the SARS-CoV-2 virus is the second survey conducted among SAS employees. Its realization enabled monitoring of the impact of booster vaccination doses and the spread of the Omicron variant in a defined group of people. The total seropositivity of the involved SAS employees in autumn 2022 was 96.04%. In the group of vaccinated participants (1,189) the seropositivity rate was 99.5%, while among unvaccinated participants (176) it was 72.73%. By October 2022, when the study was conducted, 65.05% (888) of the participants have had a positive PCR/Ag test for SARS-CoV-2 at least once. Based on the presence of antibodies against the nucleoprotein (NCP) of SARS-CoV-2 it was proven, that 27.39% of participants (25.12% of vaccinated; 51.22% of non-vaccinated) who have never had a positive PCR/Ag test for SARS-CoV-2, overcame the COVID-19. According to self-assessment of the disease course, it was shown that a severe course occurred in 6.31% of the participants who overcame the disease without prior vaccination and in 1.44% of the participants who overcame COVID-19 after completing the baseline vaccination scheme. The most significant finding of the study is the evidence of significantly lower levels of specific antibodies after overcoming the Omicron variant of SARS-CoV-2, and thus its reduced immunogenicity compared to ancestral virus and earlier variants of concern.
这项针对SARS-CoV-2病毒特异性抗体的血清阳性率研究是在SAS员工中进行的第二次调查。它的实现使监测加强疫苗接种剂量的影响和欧米克隆变异在特定人群中的传播成为可能。2022年秋季SAS员工血清总阳性率为96.04%。接种组(1189人)血清阳性率为99.5%,未接种组(176人)血清阳性率为72.73%。到2022年10月进行这项研究时,65.05%(888)的参与者至少一次对SARS-CoV-2进行了PCR/Ag检测阳性。基于SARS-CoV-2核蛋白(NCP)抗体的存在,证明27.39%的参与者(25.12%的接种者;51.22%未接种疫苗的人(PCR/Ag检测从未呈阳性)克服了COVID-19。根据病程自我评估,未接种疫苗的患者中有6.31%出现严重病程,完成基线疫苗接种方案的患者中有1.44%出现严重病程。该研究最重要的发现是,在克服SARS-CoV-2的Omicron变体后,特异性抗体水平显着降低,因此与祖先病毒和早期受关注的变体相比,其免疫原性降低。
{"title":"Influence of the SARS-CoV-2 Omicron (B.1.1.529) variant and booster vaccine doses on the seroprevalence of specific IgG antibodies in the staff of the Slovak Academy of Sciences","authors":"I. Kajanová, L. Jelenska, Ľ. Lukáčiková, Katarina Grossmannova, Martina Belisova, Nikola Istvanova, Natalia Gasparovicová, V. Zelník, S. Pastoreková, Z. Radiková, J. Kopáček","doi":"10.3389/av.2023.11637","DOIUrl":"https://doi.org/10.3389/av.2023.11637","url":null,"abstract":"The presented seroprevalence study focused on specific antibodies to the SARS-CoV-2 virus is the second survey conducted among SAS employees. Its realization enabled monitoring of the impact of booster vaccination doses and the spread of the Omicron variant in a defined group of people. The total seropositivity of the involved SAS employees in autumn 2022 was 96.04%. In the group of vaccinated participants (1,189) the seropositivity rate was 99.5%, while among unvaccinated participants (176) it was 72.73%. By October 2022, when the study was conducted, 65.05% (888) of the participants have had a positive PCR/Ag test for SARS-CoV-2 at least once. Based on the presence of antibodies against the nucleoprotein (NCP) of SARS-CoV-2 it was proven, that 27.39% of participants (25.12% of vaccinated; 51.22% of non-vaccinated) who have never had a positive PCR/Ag test for SARS-CoV-2, overcame the COVID-19. According to self-assessment of the disease course, it was shown that a severe course occurred in 6.31% of the participants who overcame the disease without prior vaccination and in 1.44% of the participants who overcame COVID-19 after completing the baseline vaccination scheme. The most significant finding of the study is the evidence of significantly lower levels of specific antibodies after overcoming the Omicron variant of SARS-CoV-2, and thus its reduced immunogenicity compared to ancestral virus and earlier variants of concern.","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44382588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heat inactivation by high temperature as an approach to combat infections caused by airborne pathogens 高温灭活是一种对抗由空气传播的病原体引起的感染的方法
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-06-27 DOI: 10.3389/av.2023.11640
M. Sláviková, J. Strukova, B. Klempa, F. Simančík, S. Pastoreková, V. Zelník, J. Kopáček
The current pandemic of SARS-CoV-2 coronavirus infection has highlighted the importance of control measures to combat infections caused by airborne pathogens. Non-specific actions include various means of microorganism inactivation by chemical or physical methods targeting structural components of a given pathogen. Exposure of viruses and bacteria to elevated temperatures is one of the effective methods for discharging their harmful potential. Using a model of the Human Adenovirus 5 exposed to elevated temperatures with subsequent titration of the virus in vitro in A549 cells, we showed a dramatic decrease of the virus titer after heat treatment for 5 s at temperatures over 100°C. To verify the potential of the heat inactivation in a closed environment, the prototype of a high-capacity pathogen-cleaning device was constructed and tested. Application of the device for 2 h at an airflow rate of 900 m3/h in a room of 226 m3 reduced the total number of microorganisms in the air by more than 50% at all collection sites in the room.
当前严重急性呼吸系统综合征冠状病毒2型感染的大流行凸显了控制措施对抗空气传播病原体引起的感染的重要性。非特异性作用包括通过针对给定病原体的结构成分的化学或物理方法使微生物失活的各种手段。将病毒和细菌暴露在高温下是释放其有害潜能的有效方法之一。使用暴露于高温下的人类腺病毒5的模型,随后在A549细胞中对病毒进行体外滴定,我们发现在超过100°C的温度下热处理5 s后,病毒滴度显著降低。为了验证在封闭环境中热灭活的潜力,构建并测试了高容量病原体清洁装置的原型。在226立方米的房间中以900立方米/小时的气流速度应用该装置2小时,使房间中所有收集点的空气中微生物总数减少了50%以上。
{"title":"Heat inactivation by high temperature as an approach to combat infections caused by airborne pathogens","authors":"M. Sláviková, J. Strukova, B. Klempa, F. Simančík, S. Pastoreková, V. Zelník, J. Kopáček","doi":"10.3389/av.2023.11640","DOIUrl":"https://doi.org/10.3389/av.2023.11640","url":null,"abstract":"The current pandemic of SARS-CoV-2 coronavirus infection has highlighted the importance of control measures to combat infections caused by airborne pathogens. Non-specific actions include various means of microorganism inactivation by chemical or physical methods targeting structural components of a given pathogen. Exposure of viruses and bacteria to elevated temperatures is one of the effective methods for discharging their harmful potential. Using a model of the Human Adenovirus 5 exposed to elevated temperatures with subsequent titration of the virus in vitro in A549 cells, we showed a dramatic decrease of the virus titer after heat treatment for 5 s at temperatures over 100°C. To verify the potential of the heat inactivation in a closed environment, the prototype of a high-capacity pathogen-cleaning device was constructed and tested. Application of the device for 2 h at an airflow rate of 900 m3/h in a room of 226 m3 reduced the total number of microorganisms in the air by more than 50% at all collection sites in the room.","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42830268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The modulation of metabolomics and antioxidant stress is involved in the effect of nitazoxanide against influenza A virus in vitro 代谢组学和抗氧化应激的调节参与了硝唑尼特抗甲型流感病毒的体外作用
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-06-23 DOI: 10.3389/av.2023.11612
Zhen Huang, Haihong Zheng, Yanping Wang, Xiao-yang Wang, Chunmei Wang, Yingchun Liu, Wen Zhou, Zhaoxiong Wang, Ke‐Zhi Zhang
The prevalence of highly infectious influenza A virus (IAV) is still a major threat to global human health. Nitazoxanide (NTZ) possesses potent antiviral properties against the influenza virus. However, the role of small molecular metabolites and antioxidant stress in the NTZ’s anti-influenza virus mechanism is not yet fully understood. This study compared the changes in cellular metabolism, ROS levels, antioxidant enzyme activities, and Keap-1/Nrf2 pathway in IAV-infected MDCK cells after NTZ treatment in vitro, using LC-MS-based metabolomics, flow cytometry, immunoblot. We observed that the NTZ treatment in the IAV-infected cells drastically altered the metabolism of small molecules, among which eleven metabolites were highly relevant to NTZ. The virus induced oxidative stress was also remarkably suppressed by NTZ. Meanwhile, the Nrf2 pathway and some proteins with modulating antiviral activity were activated after NTZ treatment, protecting cells from IAV injury. Therefore, regulation of the intracellular oxidative state is the primary outcome of NTZ treatment, which may underpin an antiviral mechanism attributed to the thiazolide.
高传染性甲型流感病毒(IAV)的流行仍然是对全球人类健康的主要威胁。Nitazoxanide (NTZ)对流感病毒具有有效的抗病毒特性。然而,小分子代谢物和抗氧化应激在NTZ抗流感病毒机制中的作用尚不完全清楚。本研究采用lc - ms代谢组学、流式细胞术、免疫印迹等方法,比较体外NTZ处理iav感染MDCK细胞后细胞代谢、ROS水平、抗氧化酶活性及Keap-1/Nrf2通路的变化。我们观察到,在iav感染的细胞中,NTZ处理显著改变了小分子的代谢,其中11种代谢物与NTZ高度相关。NTZ对病毒诱导的氧化应激也有显著的抑制作用。同时,NTZ处理后Nrf2通路和一些抗病毒活性调节蛋白被激活,保护细胞免受IAV损伤。因此,细胞内氧化状态的调节是NTZ治疗的主要结果,这可能是噻唑类药物抗病毒机制的基础。
{"title":"The modulation of metabolomics and antioxidant stress is involved in the effect of nitazoxanide against influenza A virus in vitro","authors":"Zhen Huang, Haihong Zheng, Yanping Wang, Xiao-yang Wang, Chunmei Wang, Yingchun Liu, Wen Zhou, Zhaoxiong Wang, Ke‐Zhi Zhang","doi":"10.3389/av.2023.11612","DOIUrl":"https://doi.org/10.3389/av.2023.11612","url":null,"abstract":"The prevalence of highly infectious influenza A virus (IAV) is still a major threat to global human health. Nitazoxanide (NTZ) possesses potent antiviral properties against the influenza virus. However, the role of small molecular metabolites and antioxidant stress in the NTZ’s anti-influenza virus mechanism is not yet fully understood. This study compared the changes in cellular metabolism, ROS levels, antioxidant enzyme activities, and Keap-1/Nrf2 pathway in IAV-infected MDCK cells after NTZ treatment in vitro, using LC-MS-based metabolomics, flow cytometry, immunoblot. We observed that the NTZ treatment in the IAV-infected cells drastically altered the metabolism of small molecules, among which eleven metabolites were highly relevant to NTZ. The virus induced oxidative stress was also remarkably suppressed by NTZ. Meanwhile, the Nrf2 pathway and some proteins with modulating antiviral activity were activated after NTZ treatment, protecting cells from IAV injury. Therefore, regulation of the intracellular oxidative state is the primary outcome of NTZ treatment, which may underpin an antiviral mechanism attributed to the thiazolide.","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42413702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Study of anti-S1-protein IgG antibody levels as potential correlates of protection against breakthrough infection with SARS-CoV-2 Omicron BA.1 and BA.2 variants 抗S1-蛋白IgG抗体水平作为预防严重急性呼吸系统综合征冠状病毒2型奥密克戎BA.1和BA.2变异株突破性感染的潜在相关性的研究
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-06-22 DOI: 10.3389/av.2023.11652
I. Kajanová, Z. Radiková, Ľ. Lukáčiková, L. Jelenska, Katarina Grossmannova, Martina Belisova, J. Kopáček, S. Pastoreková
Despite considerable efforts, the scientific community has not yet succeeded to define uniform correlate of protection (CoP) against SARS-CoV-2 infections based on the level of specific (receptor-binding domain (RBD)-targeting or neutralizing) antibodies (Perry et al., 2022). Obviously, this is because of the high complexity and great interindividual variability of the immune response. Although the share of cellular immunity in the response to SARS-CoV-2 infection is considerable, it would not be appropriate to underestimate the protective function of specific antibodies. Increase in their level generally correlates with a decrease in the probability of infection as well as the probability of a more severe course of the disease (Khoury et al., 2021). Determining the quantity of specific antibodies providing CoP is, however, challenging precisely in view of the individual characteristics of the T-cell branch of the immune system. However, that does not diminish the significance of studying the protective function of antibodies generated after vaccination or infection with different variants of SARS-CoV-2 against breakthrough infections with new variants of the virus. Antibodies against the RBD domain of the S1 subunit of the Spike protein have the greatest importance in the neutralization of viral particles (Dolscheid-Pommerich et al., 2022). At the same time, the OPEN ACCESS
尽管做出了相当大的努力,但科学界尚未成功地根据特异性(受体结合域(RBD)-靶向或中和)抗体的水平来定义针对严重急性呼吸系统综合征冠状病毒2型感染的统一保护相关性(CoP)(Perry等人,2022)。显然,这是因为免疫反应的高度复杂性和个体间的巨大变异性。尽管细胞免疫在应对严重急性呼吸系统综合征冠状病毒2型感染中的份额相当大,但低估特定抗体的保护功能是不合适的。它们水平的增加通常与感染概率的降低以及更严重病程的概率有关(Khoury等人,2021)。然而,准确地考虑到免疫系统T细胞分支的个体特征,确定提供CoP的特异性抗体的数量是具有挑战性的。然而,这并没有削弱研究接种疫苗或感染不同变异的严重急性呼吸系统综合征冠状病毒2型后产生的抗体对新变异病毒突破性感染的保护作用的重要性。针对刺突蛋白S1亚基RBD结构域的抗体在中和病毒颗粒中具有最大的重要性(Dolscheid-Pommerich等人,2022)。同时,OPEN ACCESS
{"title":"Study of anti-S1-protein IgG antibody levels as potential correlates of protection against breakthrough infection with SARS-CoV-2 Omicron BA.1 and BA.2 variants","authors":"I. Kajanová, Z. Radiková, Ľ. Lukáčiková, L. Jelenska, Katarina Grossmannova, Martina Belisova, J. Kopáček, S. Pastoreková","doi":"10.3389/av.2023.11652","DOIUrl":"https://doi.org/10.3389/av.2023.11652","url":null,"abstract":"Despite considerable efforts, the scientific community has not yet succeeded to define uniform correlate of protection (CoP) against SARS-CoV-2 infections based on the level of specific (receptor-binding domain (RBD)-targeting or neutralizing) antibodies (Perry et al., 2022). Obviously, this is because of the high complexity and great interindividual variability of the immune response. Although the share of cellular immunity in the response to SARS-CoV-2 infection is considerable, it would not be appropriate to underestimate the protective function of specific antibodies. Increase in their level generally correlates with a decrease in the probability of infection as well as the probability of a more severe course of the disease (Khoury et al., 2021). Determining the quantity of specific antibodies providing CoP is, however, challenging precisely in view of the individual characteristics of the T-cell branch of the immune system. However, that does not diminish the significance of studying the protective function of antibodies generated after vaccination or infection with different variants of SARS-CoV-2 against breakthrough infections with new variants of the virus. Antibodies against the RBD domain of the S1 subunit of the Spike protein have the greatest importance in the neutralization of viral particles (Dolscheid-Pommerich et al., 2022). At the same time, the OPEN ACCESS","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47497620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of microbial diversity of respiratory tract between COVID-19 patients and healthy population COVID-19患者与健康人群呼吸道微生物多样性比较
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-06-22 DOI: 10.3389/av.2023.11664
Klaudia Babišová, Patrik Krumpolec, Dominik Hadžega, P. Sabaka, P. Jackuliak, G. Minárik, M. Hyblová
Since its outbreak in late 2019, the SARS-CoV-2 virus has been the main subject of interest for a number of studies. Clinical manifestations are ranging from asymptomatic to mild and severe. Major risk factors for developing severe COVID-19 are age and comorbidities, although younger people suffer from severe COVID-19 as well. One of the explanations for why can be the composition of respiratory tract microbiota. In this article, we review studies linking respiratory tract microbiome and its changes during COVID-19 infection. The respiratory tract microbiome helps shape immunity and it is assumed that it can affect the outcome of several viral infections. Several studies show differences in the microbial composition of the respiratory tract between COVID-19 patients and healthy individuals. The diversity of the respiratory tract microbiome is reduced with increasing severity of COVID-19.
自2019年底爆发以来,SARS-CoV-2病毒一直是许多研究感兴趣的主要主题。临床表现从无症状到轻、重度不等。发生严重COVID-19的主要风险因素是年龄和合并症,尽管年轻人也会患严重的COVID-19。其中一种解释可能是呼吸道微生物群的组成。本文综述了COVID-19感染期间呼吸道微生物组及其变化的相关研究。呼吸道微生物群有助于塑造免疫力,据推测它可以影响几种病毒感染的结果。几项研究表明,COVID-19患者与健康个体之间呼吸道微生物组成存在差异。呼吸道微生物组的多样性随着COVID-19严重程度的增加而减少。
{"title":"Comparison of microbial diversity of respiratory tract between COVID-19 patients and healthy population","authors":"Klaudia Babišová, Patrik Krumpolec, Dominik Hadžega, P. Sabaka, P. Jackuliak, G. Minárik, M. Hyblová","doi":"10.3389/av.2023.11664","DOIUrl":"https://doi.org/10.3389/av.2023.11664","url":null,"abstract":"Since its outbreak in late 2019, the SARS-CoV-2 virus has been the main subject of interest for a number of studies. Clinical manifestations are ranging from asymptomatic to mild and severe. Major risk factors for developing severe COVID-19 are age and comorbidities, although younger people suffer from severe COVID-19 as well. One of the explanations for why can be the composition of respiratory tract microbiota. In this article, we review studies linking respiratory tract microbiome and its changes during COVID-19 infection. The respiratory tract microbiome helps shape immunity and it is assumed that it can affect the outcome of several viral infections. Several studies show differences in the microbial composition of the respiratory tract between COVID-19 patients and healthy individuals. The diversity of the respiratory tract microbiome is reduced with increasing severity of COVID-19.","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44830063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phaseolus vulgaris alphaendornavirus-1 is frequent in bean germplasm in Slovakia and shows low molecular variability 菜豆αendornavirus-1在斯洛伐克的大豆种质中很常见,并且表现出低分子变异性
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-06-05 DOI: 10.3389/av.2023.11484
M. Mrkvová, Adam Achs, P. Alaxin, Z. Šubr, L. Predajňa, E. Zetochova, P. Hauptvogel, Katarína Šoltýs, T. Candresse, M. Glasa
Phaseolus vulgaris alphaendornavirus-1 (PvEV-1, family Endornaviridae) was identified by ribodepleted total RNA high-throughput sequencing in the virome of two bean plants (Phaseouls vulgaris L.) grown in a garden in western Slovakia. Two nearly complete PvEV-1 genomes (ca. 14.06 kb, named PV1 and PV2) were assembled, showing 99.9% nucleotide identity, while their nucleotide identity with the reference PvEV-1 genome (NC_039217) reached 98.4%. Two primer pairs spanning the viral helicase encoding region and sequence upstream of the RNA-dependent RNA polymerase were designed and used to confirm the presence of the virus in the original bean samples by RT-PCR. A subsequent search for PvEV-1 presence in Slovakia was focused on two groups of samples: 1) bean plants grown under open field conditions and sampled during the vegetation period and 2) bean accessions grown from seeds obtained from a Slovak and French bean germplasm collection. Based on RT-PCR results, 4 out of 15 bean samples from open fields and 12 out of 21 bean accessions from the curated germplasm collection tested PvEV-1-positive. Interestingly, sequencing of RT-PCR products revealed that all amplified isolates are identical in the two amplified genomic portion which is also identical to those of the PV1 and PV2 isolates. These results suggest a relatively high incidence of PvEV-1 in bean in Slovakia. This is the first evidence and characterization of PvEV-1 from bean plants in Europe.
在斯洛伐克西部花园中生长的两种豆类植物(Phaseouls vulgaris L.)的病毒组中,通过核糖贫化总RNA高通量测序鉴定了Phaseolus vulgariaαendornavirus-1(PvEV-1,内核糖核酸病毒科)。组装了两个几乎完整的PvEV-1基因组(约14.06kb,命名为PV1和PV2),显示99.9%的核苷酸同一性,与参考PvEV-1基因组(NC_039217)的核苷酸同源性达到98.4%。随后对PvEV-1在斯洛伐克的存在进行了研究,重点研究了两组样本:1)在开阔地条件下生长并在植被期取样的豆类植物;2)从斯洛伐克和法国豆类种质收集中获得的种子中生长的豆类材料。根据RT-PCR结果,来自开阔地的15份豆类样品中有4份和来自精选种质收藏的21份豆类材料中有12份检测出PvEV-1阳性。有趣的是,RT-PCR产物的测序显示,所有扩增的分离株在两个扩增的基因组部分中是相同的,这也与PV1和PV2分离株的基因组部分相同。这些结果表明斯洛伐克豆类中PvEV-1的发病率相对较高。这是欧洲首次从豆类植物中获得PvEV-1的证据和特征。
{"title":"Phaseolus vulgaris alphaendornavirus-1 is frequent in bean germplasm in Slovakia and shows low molecular variability","authors":"M. Mrkvová, Adam Achs, P. Alaxin, Z. Šubr, L. Predajňa, E. Zetochova, P. Hauptvogel, Katarína Šoltýs, T. Candresse, M. Glasa","doi":"10.3389/av.2023.11484","DOIUrl":"https://doi.org/10.3389/av.2023.11484","url":null,"abstract":"Phaseolus vulgaris alphaendornavirus-1 (PvEV-1, family Endornaviridae) was identified by ribodepleted total RNA high-throughput sequencing in the virome of two bean plants (Phaseouls vulgaris L.) grown in a garden in western Slovakia. Two nearly complete PvEV-1 genomes (ca. 14.06 kb, named PV1 and PV2) were assembled, showing 99.9% nucleotide identity, while their nucleotide identity with the reference PvEV-1 genome (NC_039217) reached 98.4%. Two primer pairs spanning the viral helicase encoding region and sequence upstream of the RNA-dependent RNA polymerase were designed and used to confirm the presence of the virus in the original bean samples by RT-PCR. A subsequent search for PvEV-1 presence in Slovakia was focused on two groups of samples: 1) bean plants grown under open field conditions and sampled during the vegetation period and 2) bean accessions grown from seeds obtained from a Slovak and French bean germplasm collection. Based on RT-PCR results, 4 out of 15 bean samples from open fields and 12 out of 21 bean accessions from the curated germplasm collection tested PvEV-1-positive. Interestingly, sequencing of RT-PCR products revealed that all amplified isolates are identical in the two amplified genomic portion which is also identical to those of the PV1 and PV2 isolates. These results suggest a relatively high incidence of PvEV-1 in bean in Slovakia. This is the first evidence and characterization of PvEV-1 from bean plants in Europe.","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46768028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A novel deltacryptic virus identified in Allium cepa from Brazil. 一种在巴西葱属植物中发现的新型deltacrypa病毒。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.4149/av_2023_111
José Ailton Cruz, Adriano Márcio Freire, Júlio Carlos Polimeni, Rosana Blawid

 This work describes a novel partitivirus genome assembled from RNA-seq data generated from onion tissue from fields in Brazil. A new partitivirus genome composed of three dsRNAs, which was closely related to arhar cryptic virus 1, was assembled from Allium cepa samples from Brazil. The genomic sequences were also identified from available transcriptomic datasets of onion samples from China, Czech Republic, India, South Korea and USA. According to the species demarcation in the Partitiviridae family, the new virus was classified into the genus Deltapartitivirus with the suggested name of allium deltapartitivirus. This is the first report of the occurrence of a cryptic virus in plants of the genus Allium, and therefore, this work contributes to the understanding of the genetic diversity of partitiviruses  that infect the genus Allium. Keywords: Allium sp.; high-throughput sequencing; partitiviruses.

这项工作描述了一种新的部分病毒基因组,该基因组是从巴西田地的洋葱组织中产生的RNA-seq数据组装而成。从巴西的葱属植物中组装出了与arhar隐病毒1型亲缘关系较近的由3个dsrna组成的部分病毒基因组。基因组序列还从来自中国、捷克共和国、印度、韩国和美国的洋葱样本的转录组数据集中进行了鉴定。根据病毒科的种划分,将新病毒归为Deltapartitivirus属,建议命名为allium Deltapartitivirus。这是首次报道葱属植物中出现隐病毒,因此,这项工作有助于了解感染葱属植物的部分病毒的遗传多样性。关键词:葱属植物;高通量测序;partitiviruses。
{"title":"A novel deltacryptic virus identified in Allium cepa from Brazil.","authors":"José Ailton Cruz,&nbsp;Adriano Márcio Freire,&nbsp;Júlio Carlos Polimeni,&nbsp;Rosana Blawid","doi":"10.4149/av_2023_111","DOIUrl":"https://doi.org/10.4149/av_2023_111","url":null,"abstract":"<p><p> This work describes a novel partitivirus genome assembled from RNA-seq data generated from onion tissue from fields in Brazil. A new partitivirus genome composed of three dsRNAs, which was closely related to arhar cryptic virus 1, was assembled from Allium cepa samples from Brazil. The genomic sequences were also identified from available transcriptomic datasets of onion samples from China, Czech Republic, India, South Korea and USA. According to the species demarcation in the Partitiviridae family, the new virus was classified into the genus Deltapartitivirus with the suggested name of allium deltapartitivirus. This is the first report of the occurrence of a cryptic virus in plants of the genus Allium, and therefore, this work contributes to the understanding of the genetic diversity of partitiviruses  that infect the genus Allium. Keywords: Allium sp.; high-throughput sequencing; partitiviruses.</p>","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9159734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Notoginsenoside R1 inhibits hepatitis B virus replication by modulating SIRT1 activity. 三七皂苷R1通过调节SIRT1活性抑制乙型肝炎病毒复制。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.4149/av_2023_105
Wujing Zhang, Jingjing Cui, Lichun Li, Lijuan Chai, Qingling Hou, Huaqi Yu

The hepatitis B virus (HBV) infection remains highly prevalent globally. The present study aimed to explore the possible therapeutic effect of notoginsenoside R1, which has attracted considerable attention due to its diverse pharmacological effects, on HBV infection. The HBV-containing hepatocellular carcinoma cell lines, HepG2 and MHCC97H, were used in this study. We first treated the two cell lines with different concentrations of notoginsenoside R1 and subsequently measured the relative levels of HBV DNA, HBV surface antigen, HBV core antigen, and sirtuin 1 (SIRT1) using reverse transcription-quantitative polymerase chain reaction and western blotting. Finally, an HBV hemodynamic replication model was created to test the effect of notoginsenoside R1 on HBV replication. Notoginsenoside R1 inhibited the replication of HBV. This inhibitory effect was mediated through the downregulation of SIRT1 activity. Additionally, the inhibition of SIRT1 activity by silencing its expression or treatment with the SIRT1 inhibitor, selisistat, suppressed HBV replication. Furthermore, our animal experiments demonstrated that notoginsenoside R1 was effective at suppressing HBV replication in vivo. Thus, notoginsenoside R1 suppresses HBV replication by downregulating SIRT1 activity in vitro and in vivo. Keywords: notoginsenoside R1; hepatitis B virus; SIRT1.

乙型肝炎病毒(HBV)感染在全球仍然非常普遍。三七皂苷R1因其多种药理作用而备受关注,本研究旨在探讨其对HBV感染的可能治疗作用。本研究使用的是含hbv的肝癌细胞系HepG2和MHCC97H。我们首先用不同浓度的三七皂苷R1处理两株细胞系,随后使用逆转录-定量聚合酶链反应和western blotting检测HBV DNA、HBV表面抗原、HBV核心抗原和sirtuin 1 (SIRT1)的相对水平。最后建立HBV血流动力学复制模型,检验三七皂苷R1对HBV复制的影响。三七皂苷R1抑制HBV复制。这种抑制作用是通过下调SIRT1活性介导的。此外,通过沉默SIRT1表达或使用SIRT1抑制剂selisistat治疗来抑制SIRT1活性,可以抑制HBV复制。此外,我们的动物实验表明,三七皂苷R1在体内有效抑制HBV复制。因此,三七皂苷R1在体外和体内通过下调SIRT1活性抑制HBV复制。关键词:三七皂苷R1;乙型肝炎病毒;SIRT1。
{"title":"Notoginsenoside R1 inhibits hepatitis B virus replication by modulating SIRT1 activity.","authors":"Wujing Zhang,&nbsp;Jingjing Cui,&nbsp;Lichun Li,&nbsp;Lijuan Chai,&nbsp;Qingling Hou,&nbsp;Huaqi Yu","doi":"10.4149/av_2023_105","DOIUrl":"https://doi.org/10.4149/av_2023_105","url":null,"abstract":"<p><p>The hepatitis B virus (HBV) infection remains highly prevalent globally. The present study aimed to explore the possible therapeutic effect of notoginsenoside R1, which has attracted considerable attention due to its diverse pharmacological effects, on HBV infection. The HBV-containing hepatocellular carcinoma cell lines, HepG2 and MHCC97H, were used in this study. We first treated the two cell lines with different concentrations of notoginsenoside R1 and subsequently measured the relative levels of HBV DNA, HBV surface antigen, HBV core antigen, and sirtuin 1 (SIRT1) using reverse transcription-quantitative polymerase chain reaction and western blotting. Finally, an HBV hemodynamic replication model was created to test the effect of notoginsenoside R1 on HBV replication. Notoginsenoside R1 inhibited the replication of HBV. This inhibitory effect was mediated through the downregulation of SIRT1 activity. Additionally, the inhibition of SIRT1 activity by silencing its expression or treatment with the SIRT1 inhibitor, selisistat, suppressed HBV replication. Furthermore, our animal experiments demonstrated that notoginsenoside R1 was effective at suppressing HBV replication in vivo. Thus, notoginsenoside R1 suppresses HBV replication by downregulating SIRT1 activity in vitro and in vivo. Keywords: notoginsenoside R1; hepatitis B virus; SIRT1.</p>","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9159735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of LEF-11 acetylation modification on the regulation of baculovirus infection. LEF-11乙酰化修饰对杆状病毒感染的调控作用。
IF 1.7 4区 医学 Q3 Medicine Pub Date : 2023-01-01 DOI: 10.4149/av_2023_104
Jiannan Wu, Shuli Shen, Xu Gao, Meng Miao, Yanping Quan, Wei Yu

Late expression factor 11 (LEF-11) is an essential protein in the regulation of Bombyx mori nucleopolyhedrovirus (BmNPV) DNA replication and late gene expression. Our recent quantitative analysis of protein acetylome revealed for the first time that LEF-11 can be acetylated at one lysine residue (K83) during viral infection, but the underlying mechanism is unclear. The acetylation level for K83 was down-regulated after 36 h post-infection by approximately 30%. To clarify the regulatory function of this modification, overlap PCR was used for site-specific mutagenesis for acetylated (K83Q) or deacetylated (K83R) mimic mutants of LEF-11. The results of viral titration and quantitative polymerase chain reaction showed that after K83 acetylation, budding virion production and the viral genome replication level were significantly upregulated. Meanwhile, the results of yeast two-hybrid (Y2H) system confirmed that K83 deacetylation modification inhibited the interaction between LEF-11 and immediate early gene 1 (IE-1). In conclusion, the acetylation of LEF-11 at K83 might enhance the interaction with IE-1 in the host cell nucleus to promote viral DNA replication, and might be one of the antiviral strategies of the silkworm host. The host inhibits virus proliferation by deacetylating LEF-11. Keywords: BmNPV; LEF-11; acetylation; virus replication; protein interaction.

晚期表达因子11 (LEF-11)是家蚕核多角病毒(BmNPV) DNA复制和晚期基因表达调控的重要蛋白。我们最近对蛋白质乙酰基的定量分析首次揭示了在病毒感染过程中,LEF-11可以在一个赖氨酸残基(K83)上乙酰化,但其潜在的机制尚不清楚。感染后36小时,K83的乙酰化水平下调约30%。为了阐明这种修饰的调控功能,我们使用重叠PCR对LEF-11的乙酰化(K83Q)或去乙酰化(K83R)模拟突变体进行了位点特异性诱变。病毒滴定和定量聚合酶链反应结果表明,K83乙酰化后,出芽病毒粒子产量和病毒基因组复制水平显著上调。同时,酵母双杂交(Y2H)系统的结果证实,K83去乙酰化修饰抑制了LEF-11与即时早期基因1 (IE-1)的相互作用。综上所述,LEF-11在K83位点的乙酰化可能增强了与宿主细胞核内IE-1的相互作用,促进了病毒DNA的复制,可能是家蚕宿主的抗病毒策略之一。宿主通过去乙酰化LEF-11抑制病毒增殖。关键词:BmNPV;LEF-11;乙酰化作用;病毒复制;蛋白质的相互作用。
{"title":"Effects of LEF-11 acetylation modification on the regulation of baculovirus infection.","authors":"Jiannan Wu,&nbsp;Shuli Shen,&nbsp;Xu Gao,&nbsp;Meng Miao,&nbsp;Yanping Quan,&nbsp;Wei Yu","doi":"10.4149/av_2023_104","DOIUrl":"https://doi.org/10.4149/av_2023_104","url":null,"abstract":"<p><p>Late expression factor 11 (LEF-11) is an essential protein in the regulation of Bombyx mori nucleopolyhedrovirus (BmNPV) DNA replication and late gene expression. Our recent quantitative analysis of protein acetylome revealed for the first time that LEF-11 can be acetylated at one lysine residue (K83) during viral infection, but the underlying mechanism is unclear. The acetylation level for K83 was down-regulated after 36 h post-infection by approximately 30%. To clarify the regulatory function of this modification, overlap PCR was used for site-specific mutagenesis for acetylated (K83Q) or deacetylated (K83R) mimic mutants of LEF-11. The results of viral titration and quantitative polymerase chain reaction showed that after K83 acetylation, budding virion production and the viral genome replication level were significantly upregulated. Meanwhile, the results of yeast two-hybrid (Y2H) system confirmed that K83 deacetylation modification inhibited the interaction between LEF-11 and immediate early gene 1 (IE-1). In conclusion, the acetylation of LEF-11 at K83 might enhance the interaction with IE-1 in the host cell nucleus to promote viral DNA replication, and might be one of the antiviral strategies of the silkworm host. The host inhibits virus proliferation by deacetylating LEF-11. Keywords: BmNPV; LEF-11; acetylation; virus replication; protein interaction.</p>","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9167035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta virologica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1